PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Pappas Ventures Names Eric Linsley Managing Partner
News | 09. 28. 2009
Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner.
